-Celeste Eng Researcher Activity Profile

Research Author Detailed Information 

Celeste Eng Publication Rate By Year

Celeste Eng has published 2 paper(s) in 2003, 1 paper(s) in 2005, 2 paper(s) in 2006, 42 paper(s) in 2007, 17 paper(s) in 2008, for a total of 64 research publications in total.

Celeste C Eng Author Information

LAST NAME: eng

FIRST NAME: Celeste

INITIALS: c

AFFILIATION:

Papers

Celeste Eng's Publication Record

1. Ethnicity-specific gene-gene interaction between IL-13 and IL-4Ralpha among African Americans with asthma. Year Published: 2007
University of California, San Francisco, San Francisco, CA 94143-2911, USA.
2. Mode effects in the center for epidemiologic studies depression (CES-D) scale: personal digital assistant vs. paper and pencil administration. Year Published: 2007
Department of Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, 77030, TX, USA. rswartz@mdanderson.org
3. BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels. Year Published: 2003
Clinical Cancer Genetics Program, Comprehensive Cancer Center, Division of Human Genetics, Department of Internal Medicine, The Ohio State University, Columbus, OH, 43210, USA.
4. Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia. Year Published: 2006
Division of Gastroenterology, University Hospitals of Cleveland and Ireland Cancer Center, Cleveland, Ohio 44106, USA. Amitabh.chak@case.edu
5. Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. Year Published: 2006
Department of Hematology and Oncology, Comprehensive Cancer Center, College of Medicine and Public Health, The Ohio State University, Columbus, Ohio 43210, USA, and Department of Pathology, Addenbrooks' Hospital, Cambridge, UK.
6. Pilot study of rosiglitazone therapy in women with breast cancer: effects of short-term therapy on tumor tissue and serum markers. Year Published: 2007
Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, Ohio, USA. lisa.yee@osumc.edu
7. Essential role for nuclear PTEN in maintaining chromosomal integrity. Year Published: 2007
Department of Radiation Oncology, College of Physicians and Surgeons, Columbia University, 630 West 168th Street, New York, NY 10032, USA.
8. Heritable clustering and pathway discovery in breast cancer integrating epigenetic and phenotypic data. Year Published: 2007
Mathematical Biosciences Institute, The Ohio State University, 231 W, 18th Avenue, Columbus, OH 43210, USA. zailong.wang@yahoo.com <zailong.wang@yahoo.com>
9. Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. Year Published: 2007
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 444, Houston, TX 77030, USA.
10. Cowden syndrome. Year Published: 2007
Center for Personalized Genetic Healthcare, Genomic Medicine Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
11. Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma. Year Published: 2007
Genomic Medicine Institute, Lerner Research Institute and Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
12. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma. Year Published: 2007
Department of Molecular Genetics, The Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
13. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Year Published: 2007
Department of Radiation Oncology, the University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. prajdas@mdanderson.org
14. Consortium approach to identifying genes for Barrett's esophagus and esophageal adenocarcinoma. Year Published: 2007
Department of Epidemiology and Biostatistics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
15. A novel PTEN mutation in Cowden syndrome is associated with a mixed degenerative-erosive arthritic process: potential molecular pathogenic mechanisms. Year Published: 2007
Department of Internal Medicine, The Ohio State University Medical Center, 1581 Dodd Drive, Columbus, OH 43210, USA. joseph.pinzone@osumc.edu
16. Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. Year Published: 2007
Department of Neurology, University Medical Center Freiburg, Germany.
17. Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Year Published: 2007
Centre for Research in Women's Health, Women's College Hospital, University of Toronto, Room 750, 790 Bay Street, 7th Floor, Toronto, ON M5G 1N8, Canada.
18. Current and emerging trends in the treatment of metastatic colorectal cancer. Year Published: 2007
Department of Gastrointestinal Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas.
19. Evidence of MEN-2 in the original description of classic pheochromocytoma. Year Published: 2007
Department of Nephrology, University of Freiburg Medical Center, Freiburg im Breisgau, Germany. hartmut.neumann@uniklinik-freiburg.de
20. Familial adenomatous polyposis in a patient with unexplained mental retardation. Year Published: 2007
Center for Personalized Genetic Healthcare, Genomic Medicine Institute and the Taussig Cancer Center, Cleveland, OH 44195, USA.
21. Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. Year Published: 2007
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 444, Houston, TX 77030, USA.
22. Cowden syndrome. Year Published: 2007
Center for Personalized Genetic Healthcare, Genomic Medicine Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
23. Association of plasma levels of F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis. Year Published: 2007
Division of Cardiology, Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York 11203-2098, USA. ecavusoglu@aol.com
24. Combining targeted therapies to enhance the effectiveness of chemotherapy in patients with treatment-refractory colorectal cancer. Year Published: 2007
Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston. ceng@mdanderson.org.
25. Is secondary haemorrhage after tonsillectomy in adults an infective condition? Objective measures of infection in a prospective cohort. Year Published: 2007
Department of ENT, Ward 45, Aberdeen Royal Infirmary, Foresterhill Road, Aberdeen AB25 2ZN, UK. farhan099@hotmail.com
26. Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. Year Published: 2007
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 444, Houston, TX 77030, USA.
27. Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab. Year Published: 2007
aDepartment of Diagnostic Radiology, Interventional Radiology Section, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030.
28. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Year Published: 2007
Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. dr.zembowicz@DermatopathologyConsultations.com
29. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Year Published: 2007
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
30. Combining targeted therapies to enhance the effectiveness of chemotherapy in patients with treatment-refractory colorectal cancer. Year Published: 2007
Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA. ceng@mdanderson.org
31. Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Year Published: 2007
1Department of Genetics, Biology and Biochemistry, University of Torino, Turin, Italy.
32. Relation of baseline plasma phospholipid levels to cardiovascular outcomes at two years in men with acute coronary syndrome referred for coronary angiography. Year Published: 2007
Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York; Division of Cardiology, Department of Medicine, Bronx Veterans Affairs Medical Center, Bronx, New York.
33. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Year Published: 2007
Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. dr.zembowicz@DermatopathologyConsultations.com
34. Breast-cancer stromal cells with TP53 mutations and nodal metastases. Year Published: 2007
Genomic Medicine Institute, Cleveland Clinic Foundation, Cleveland 44195, USA.
35. Breast-cancer stromal cells with TP53 mutations and nodal metastases. Year Published: 2007
Genomic Medicine Institute, Cleveland Clinic Foundation, Cleveland 44195, USA.
36. Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Year Published: 2007
Centre for Research in Women's Health, Women's College Hospital, University of Toronto, Room 750, 790 Bay Street, 7th Floor, Toronto, ON M5G 1N8, Canada.
37. Prediction of mortality in community-living frail elderly people with long-term care needs. Year Published: 2008
Division of General Internal Medicine, College of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
38. Caveolin-1 and caveolin-2,together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis. Year Published: 2003
Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio 43210, USA.
39. Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab. Year Published: 2007
Department of Diagnostic Radiology, Interventional Radiology Section, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA. rmurthy@di.mdacc.tmc.edu
40. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Year Published: 2007
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
41. Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination. Year Published: 2005
Clinical Cancer Genetics Program, Department of Internal Medicine, The Ohio State University, Columbus, Ohio 43210, USA.
42. Relation of baseline plasma phospholipid levels to cardiovascular outcomes at two years in men with acute coronary syndrome referred for coronary angiography. Year Published: 2007
Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA. ecavusoglu@aol.com
43. Familial adenomatous polyposis in a patient with unexplained mental retardation. Year Published: 2007
Center for Personalized Genetic Healthcare, Genomic Medicine Institute and the Taussig Cancer Center, Cleveland, OH 44195, USA.
44. Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Year Published: 2007
Department of Genetics, Biology and Biochemistry, University of Torino, Turin, Italy.
45. Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation. Year Published: 2008
Department of Hypertension at the Institute of Cardiology, Warsaw, Poland.
46. Prediction of mortality in community-living frail elderly people with long-term care needs. Year Published: 2008
Division of General Internal Medicine, College of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
47. The nuclear affairs of PTEN. Year Published: 2008
Genomic Medicine Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
48. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Year Published: 2007
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
49. Combining targeted therapies to enhance the effectiveness of chemotherapy in patients with treatment-refractory colorectal cancer. Year Published: 2007
Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA. ceng@mdanderson.org
50. Direct evidence for epithelial-mesenchymal transitions in breast cancer. Year Published: 2008
Department of Molecular Genetics, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
51. Recognition and Diagnosis of Mucopolysaccharidosis II (Hunter Syndrome). Year Published: 2008
St Louis University, 1465 S Grand Blvd, St Louis, MO 63104. rmarti41@slu.edu.
52. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome). Year Published: 2008
Department of Pediatrics, St Louis University, 1465 S Grand Blvd, St Louis, MO 63104, USA. rmarti41@slu.edu
53. Direct evidence for epithelial-mesenchymal transitions in breast cancer. Year Published: 2008
Department of Molecular Genetics, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
54. Relation of baseline plasma phospholipid levels to cardiovascular outcomes at two years in men with acute coronary syndrome referred for coronary angiography. Year Published: 2007
Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA. ecavusoglu@aol.com
55. Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Year Published: 2007
Department of Genetics, Biology and Biochemistry, University of Torino, Turin, Italy.
56. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome). Year Published: 2008
Department of Pediatrics, St Louis University, 1465 S Grand Blvd, St Louis, MO 63104, USA. rmarti41@slu.edu
57. Second-line chemotherapy use in metastatic colon cancer varies by disease responsiveness. Year Published: 2008
University of Texas Health Science Center, Houston, TX.
58. Bevacizumab in the treatment of a patient with metastatic colorectal carcinoma with brain metastases. Year Published: 2008
Department of Internal Medicine, The University of Texas M. D. Anderson Cancer Center.
59. Frequency of germline genomic homozygosity associated with cancer cases. Year Published: 2008
Genomic Medicine Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
60. Frequency of germline genomic homozygosity associated with cancer cases. Year Published: 2008
Genomic Medicine Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
61. Duplication of chromosome band 12q24.11q24.23 results in apparent Noonan syndrome. Year Published: 2008
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
62. Molecular characterisation of a common SDHB deletion in paraganglioma patients. Year Published: 2008
63. Duplication of chromosome band 12q24.11q24.23 results in apparent Noonan syndrome. Year Published: 2008
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
64. Molecular characterisation of a common SDHB deletion in paraganglioma patients. Year Published: 2008